102 | ČESKÁ A SLOVENSKÁ FARMACIE / Čes. slov. Farm. 2024;73(2):93-102 / www.csfarmacie.cz PŮVODNÍ PRÁCE Polékové hospitalizace – zkušenosti z České republiky 40. Doucet J, Jego A, Noel D, et al. Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly: A prospective study. Clin Drug Investig. 2002;22(6):385-92. 41. Dormann H, Sonst A, Muller F, et al. Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). Deutsches Arzteblatt International. 2013;110(13):213-9. 42. Cahir C, Curran C, Walsh C, et al. Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients. Front Pharmacol. 2022;13:1029067. 43. Ahern F, Sahm LJ, Lynch D, McCarthy S. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: A cross- -sectional study. Emerg Med J. 2014;31(1):24-9. 44. Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: A 6-month experience in a single center in Greece. Eur J Intern Med. 2008;19(7):505-10. 45. Cabre M, Elias L, Garcia M, et al. Avoidable hospitalizations due to adverse drug reactions in an acute geriatric unit. Analysis of 3,292 patients. Med Clin (Barc). 2018;150(6):20914. 46. Kaur U, Chakrabarti SS, Gupta GK, et al. Drug-related problems in older adults in outpatient settings: Results from a 6-year long prospective study in a tertiary hospital of north India. Geriatr Gerontol Int. 2023. 47. Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a Geriatric Unit - A prospective study of 1756 patients. Drug Saf. 2008;31(6):545-56. 48. Laatikainen O, Sneck S, Bloigu R, et al. Hospitalizations due to adverse drug events in the elderly-a retrospective register study. Front Pharmacol. 2016;7(358). 49. Helldén A, Bergman U, von Euler M, et al. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging. 2009;26(7):595-606. 50. Alvarez PA, Bril F, Castro V, et al. Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina. International Journal of Risk and Safety in Medicine. 2013;25(3):185-92. 51. von Euler M, Eliasson E, Ohlen G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006;15(3):179-84. 52. Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci. 2008;30(6):854-62. 53. Dechanont S, Jedsadayanmata A, Butthum B, Kongkaew C. Hospital Admissions Associated With Medication-Related Problems in Thai Older Patients: A Multicenter Prospective Observational Study. J Patient Saf. 2021;17(1):15-22. 54. Matanović SM, Vlahović-Palčevski V. Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs. Eur J Clin Pharmacol. 2014;70(4):483-90. 55. Haerdtlein A, Debold E, Rottenkolber M, et al. Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis. J Clin Med. 2023;12(4). 56. Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans. J Am Geriatr Soc. 2012;60(1):34-41. 57. Brandariz-Núñez D, Ferreiro-Gómez M, Suanzes J, et al. Prevalence of adverse drug reactions associated with emergency department visits and risk factors for hospitalization. Farm Hosp. 2023;47(1):T20-t5. 58. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11):1013-9. 59. Mouton JP, Njuguna C, Kramer N, et al. Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa. Medicine. 2016;95(19):e3437. 60. Davies EC, Green CF, Mottram DR, et al. Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission. Br J Clin Pharmacol. 2010;70(5):749-55. 61. Hohl CM, Karpov A, Reddekopp L, et al. ICD-10 codes used to identify adverse drug events in administrative data: a systematic review. J Am Med Inform Assoc. 2014;21(3):547-57. 62. Wickham ME, McGrail KM, Law MR, et al. Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events. Br J Clin Pharmacol. 2024. 63. Vlček J, Bártlová S, Brabcová I, et al. Minimalizace rizik a teorie tří pilířů u léčiv zvyšujících riziko pádů. Klin Farmakol Farm. 2019;33(4):30-4. 64. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. 65. De Schutter H, Hias J, Hellemans L, et al. Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients). Eur Geriatr Med. 2022;13(6):1467-76. 66. Aspirin in the primary prevention of cardiovascular disease and cancer (updated: Sep 13, 2023). In: Connor RF, editor. UpToDate: Wolters Kluwer; 2024. 67. McQuilten ZK, Thao LTP, Pasricha SR, et al. Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial. Ann Intern Med. 2023;176(7):913-21. 68. Cloud GC, Williamson JD, Thao LTP, et al. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023;6(7):e2325803. 69. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(38):3720-826. 70. Vrablík M, Cífková R, Tuka V, Linhart A. Doporučený postup Evropské kardiologické společnosti pro prevenci kardiovaskulárních onemocnění v klinické praxi 2021.Souhrn dokumentu připravený Českou kardiologickou společností. Cor Vasa. 2022;64(2):165-211. 71. Wojszel ZB, Kasiukiewicz A. A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward. BMC Geriatr. 2019;19(1):242. 72. Lipska KJ, Ross JS, Miao Y, et al. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175(3):356-62. 73. Lederle LI, Steinman MA, Jing B, et al. Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes. J Am Geriatr Soc. 2022;70(7):2019-28. 74. Očovská Z, Maříková M, Vlček J. Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study. Front Pharmacol. 2023;14:1088900. 75. Wang GH, Morris EJ, Smith SM, et al. Continued potassium supplementation use following loop diuretic discontinuation in older adults: An evaluation of a prescribing cascade relic. J Am Geriatr Soc. 2023;71(2):505-515. 76. Watson KE, Dhaliwal K, Robertshaw S, et al. Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process. Am J Kidney Dis. 2023;81(5):564-74. 77. Coppes T, Hazen ACM, Zwart DLM, et al. Characteristics and preventability of medication-related admissions for acute kidney injury and dehydration in elderly patients. Eur J Clin Pharmacol. 2024. doi: 10.1007/s00228-024-03704-7. 78. Liamis G, Filippatos TD, Elisaf MS. Thiazide-associated hyponatremia in the elderly: what the clinician needs to know. J Geriatr Cardiol. 2016;13(2):175-82. 79. International Pharmaceutical Federation (FIP). Medication review and medicines use review: A toolkit for pharmacists. The Hague: International Pharmaceutical Federation; 2022.
RkJQdWJsaXNoZXIy NDA4Mjc=